Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · IEX Real-Time Price · USD
229.89
-2.80 (-1.20%)
May 2, 2024, 4:00 PM EDT - Market closed

CRL Revenue

In the year 2023, Charles River Laboratories International had annual revenue of $4.13B with 3.86% growth. Revenue in the quarter ending December 30, 2023 was $1.01B, a -7.85% decrease year-over-year.

Revenue (ttm)
$4.13B
Revenue Growth
+3.86%
P/S Ratio
2.87
Revenue / Employee
$189,422
Employees
21,800
Market Cap
11.80B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 30, 20234.13B153.35M3.86%
Dec 31, 20223.98B435.90M12.31%
Dec 25, 20213.54B616.23M21.08%
Dec 26, 20202.92B302.71M11.55%
Dec 28, 20192.62B355.13M15.67%
Dec 29, 20182.27B408.50M21.99%
Dec 30, 20171.86B176.17M10.48%
Dec 31, 20161.68B318.13M23.34%
Dec 26, 20151.36B65.64M5.06%
Dec 27, 20141.30B132.13M11.34%
Dec 28, 20131.17B36.00M3.19%
Dec 29, 20121.13B-13.12M-1.15%
Dec 31, 20111.14B9.23M0.81%
Dec 25, 20101.13B-38.23M-3.26%
Dec 26, 20091.17B-123.66M-9.55%
Dec 27, 20081.30B64.67M5.26%
Dec 29, 20071.23B172.24M16.27%
Dec 30, 20061.06B65.06M6.55%
Dec 31, 2005993.33M269.11M37.16%
Dec 25, 2004724.22M110.50M18.00%
Dec 27, 2003613.72M59.09M10.65%
Dec 28, 2002554.63M89.00M19.11%
Dec 29, 2001465.63M159.05M51.88%
Dec 30, 2000306.59M75.17M32.48%
Dec 25, 1999231.41M26.35M12.85%
Dec 26, 1998205.06M34.35M20.12%
Dec 27, 1997170.71M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Tenet Healthcare 20.91B
DaVita 12.14B
Incyte 3.77B
Dr. Reddy's Laboratories 2.99B
United Therapeutics 2.50B
Medpace Holdings 1.96B
Insulet 1.70B
Sarepta Therapeutics 1.40B
Revenue Rankings